Enzymotec (Enzymotec) Marketable Securities : $29.13 Mil (As of Sep. 2017)

View and export this data going back to 2013. Start your Free Trial

What is Enzymotec Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Enzymotec's Marketable Securities for the quarter that ended in Sep. 2017 was $29.13 Mil.

Enzymotec's annual Marketable Securities increased from Dec. 2014 ($1.94 Mil) to Dec. 2015 ($6.01 Mil) and increased from Dec. 2015 ($6.01 Mil) to Dec. 2016 ($19.59 Mil).

Enzymotec Marketable Securities Historical Data

The historical data trend for Enzymotec's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymotec Marketable Securities Chart

Enzymotec Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Marketable Securities

Get a 7-Day Free Trial

1.94

6.01

19.59

Enzymotec Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17
Marketable Securities	Get a 7-Day Free Trial															34.01	19.59	33.69	29.81	29.13

Enzymotec Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Enzymotec (NAS:ENZY) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Enzymotec Marketable Securities Related Terms

Thank you for viewing the detailed overview of Enzymotec's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzymotec (Enzymotec) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzymotec Ltd (NAS:ENZY) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.enzymotec.com

Enzymotec Ltd is nutritional and food ingredients company. It develops and manufactures nutritional ingredients and medical foods based on proprietary technologies. Its product portfolio includes Infat, K-Real, Enzy PS solutions, Vayacog, Vayarin and Vayaroll. The company has Nutrition and Vaya Pharma reportable segments. It derives majority of its revenues from Nutrition segment. The firm mainly operates in America, Europe, Australia, Asia, and Israel.

Enzymotec (Enzymotec) Headlines

From GuruFocus

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson • 12-07-2015

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi • 12-20-2016

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon • 07-01-2016